The ACI Certification is a key part of The ACI’s vision for a sustainable future for the UK CBD sector and further emboldens The ACI’s mission to nurture an industry that puts public safety first.
The ACI Certification is composed of three tiers, each representing the necessary steps to gaining full Novel Foods Authorisation from the appropriate regulatory bodies.
*due to current Covid-19 situation and restrictions
audits will be performed virtually
The ACI Regulatory and Compliance Unit
To facilitate this new drive for safety and quality The ACI is establishing a new Regulatory and Compliance Unit, under the leadership of Dr Parveen Bhatarah, to support its members with both The ACI accreditation and Novel Foods dossier development.
Comprehensive Safety Assessments for CBD
The Novel Foods authorisation process is a safety assessment of CBD. The ACI is gathering, with the collaboration of toxicology experts, Novel Foods experts and our members, the necessary safety and toxicology data to build robust Novel Foods authorisation dossiers for The ACI members.
Submitting credible Novel Foods authorisation dossiers is the only way the industry can stay on UK shelves, as a food supplement, beyond the FSA’s deadline of 31 March 2021.
The ACI Certification will finally give consumers and retailers confidence in CBD products on the market in the UK. This will give the UK an invaluable lead in the Global CBD industry.